Signaling Pathways
Product Name | CAS No. | Specification | Application | Registration |
Streptozotocin (STZ) | 18883-66-4 | 98+% | Diabetes Models | |
Decitabine | 2353-33-5 | 99+% | ||
Lenalidomide (CC-5013) | 191732-72-6 | 98+% | ||
Imatinib Mesylate | 220127-57-1 | 99+% | ||
Letrozole | 112809-51-5 | 99+% | ||
Fulvestrant | 129453-61-8 | 99+% | Estrogen/progestogen Receptor antagonist | CAS 129453-61-8 | Autophagy activator | Apoptosis related activator | |
Anastrozole | 120511-73-1 | 99+% | ||
Bicalutamide | 90357-06-5 | 98+% | ||
Olaparib | 763113-22-0 | 99+% | ||
Elagolix Sodium | 832720-36-2 | 99+% | ||
5-Fluorouracil (5-FU) | 51-21-8 | 98+% | Nucleoside Analog/Antimetabolite inhibitor | HIV inhibitor | |
Oxaliplatin | 61825-94-3 | 99+% | ||
Abacavir Sulfate | 188062-50-2 | 98+% | ||
Cyclophosphamide Monohydrate | 6055-19-2 | 98+% | ||
Ifosfamide | 3778-73-2 | 98+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks